{"id":5307,"date":"2024-01-05T17:46:10","date_gmt":"2024-01-05T22:46:10","guid":{"rendered":"https:\/\/www.lrmm.com\/fr\/e-quipe\/"},"modified":"2025-09-04T11:36:26","modified_gmt":"2025-09-04T15:36:26","slug":"boldeanu-irina","status":"publish","type":"equipe","link":"https:\/\/www.lrmm.com\/fr\/e-quipe\/avocats\/boldeanu-irina","title":{"rendered":"Boldeanu Irina"},"content":{"rendered":"\n<p>Irina Boldeanu s\u2019est jointe \u00e0 notre \u00e9quipe de litige en 2023.<\/p>\n\n\n\n<p>Reconnue dans les \u00e9ditions de <em>Best Lawyers: Ones to Watch in Canada\u00ae<\/em> depuis 2024, Irina est une avocate en litige d\u00e9vou\u00e9e et ax\u00e9e sur les r\u00e9sultats, passionn\u00e9e par les litiges civils et commerciaux complexes, notamment la d\u00e9fense d\u2019actions collectives et les litiges commerciaux. Elle est particuli\u00e8rement attentive aux besoins des clients des secteurs de la sant\u00e9, des technologies et de l&rsquo;industrie pharmaceutique.<\/p>\n\n\n\n<p>D\u00e9tenant un baccalaur\u00e9at en droit (LL.B.), un Juris Doctor (J.D.) et un baccalaur\u00e9at en sciences biom\u00e9dicales (B.Sc.), elle apporte une combinaison distinctive de perspicacit\u00e9 juridique et de rigueur scientifique \u00e0 sa pratique. Forte d&rsquo;une solide formation universitaire en droit et en sciences biom\u00e9dicales, Irina allie rigueur juridique avec une compr\u00e9hension approfondie des secteurs \u00e0 vocation scientifique.<\/p>\n\n\n\n<p>Irina plaide r\u00e9guli\u00e8rement devant la Cour sup\u00e9rieure du Qu\u00e9bec, la Cour d&rsquo;appel du Qu\u00e9bec et la Cour f\u00e9d\u00e9rale du Canada, traitant des dossiers impliquant des t\u00e9moignages d&rsquo;experts, des demandes d\u2019anonymat, des contestations proc\u00e9durales et la planification strat\u00e9gique de dossiers dans le cadre de litiges \u00e0 enjeux \u00e9lev\u00e9s. Elle a contribu\u00e9 \u00e0 des dossiers de litige majeurs, dont un litige commercial de 93 millions de dollars, et a obtenu des d\u00e9sistements anticip\u00e9s dans des actions collectives en mati\u00e8re de protection des consommateurs.<\/p>\n\n\n\n<p>Forte d&rsquo;une exp\u00e9rience ant\u00e9rieure au sein de cabinets d&rsquo;avocats de premier plan, Irina r\u00e9dige \u00e9galement des documents juridiques complexes en mati\u00e8re de propri\u00e9t\u00e9 intellectuelle, des sciences de la vie et de la protection de la vie priv\u00e9e. Son parcours de recherche scientifique comprend des postes \u00e0 l&rsquo;Universit\u00e9 McGill et au CHUM, et des publications \u00e9valu\u00e9es par des pairs dans des domaines tels que l&rsquo;imagerie coronarienne, les risques cardiovasculaires li\u00e9s au VIH et la propri\u00e9t\u00e9 intellectuelle dans le secteur pharmaceutique.<\/p>\n\n\n\n<p>Irina est reconnue pour sa curiosit\u00e9 intellectuelle, sa r\u00e9flexion strat\u00e9gique et sa d\u00e9fense tenace des droits de ses clients, tant en salle d&rsquo;audience qu&rsquo;en dehors. Ses clients appr\u00e9cient sa capacit\u00e9 \u00e0 saisir rapidement les dimensions techniques d&rsquo;un dossier tout en fournissant des conseils strat\u00e9giques en mati\u00e8re de litige, ancr\u00e9s dans les r\u00e9alit\u00e9s commerciales.<\/p>\n\n\n\n<p><strong>Publications<\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u201cEnforcement of Foreign Judgments \u2013 December 2023\u201d, Kluwer Law International BV, Wolters Kluwer N.V, 2023.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u201cTrade Secrets \u2013 Canada\u201d, Les Nouvelles &#8211; Journal of the Licensing Executives Society, Volume LVI No. 2, 2021, <a href=\"https:\/\/ssrn.com\/abstract=3832061\">https:\/\/ssrn.com\/abstract=3832061<\/a>.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u00ab&nbsp;Cinq d\u00e9cisions d\u2019int\u00e9r\u00eat en mati\u00e8re de protection de la propri\u00e9t\u00e9 intellectuelle dans le domaine pharmaceutique en 2020 : lorsque les trait\u00e9s commerciaux internationaux s\u2019invitent dans le d\u00e9bat&nbsp;\u00bb, 2021, 33:2 CPI, <a href=\"https:\/\/www.lescpi.ca\/s\/4185\">https:\/\/www.lescpi.ca\/s\/4185<\/a>.<\/li>\n\n\n\n<li>Auteur d\u2019un article intitul\u00e9 \u00ab&nbsp;Les p\u00e9rip\u00e9ties de l\u2019affaire Drouin ou comment de riches \u0153uvres d\u2019int\u00e9r\u00eat national se sont trouv\u00e9s au c\u0153ur d\u2019un litige complexe en mati\u00e8re de propri\u00e9t\u00e9 intellectuelle&nbsp;\u00bb, <em>ROBIC, LLP Publications<\/em>, 2020, <a href=\"https:\/\/www.robic.ca\/publications\/les-peripeties-de-laffaire-drouin-succession-de-cote-drouin-c-pepin\/\">Les p\u00e9rip\u00e9ties de l\u2019affaire Drouin c. P\u00e9pin | Publications<\/a>.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u00ab&nbsp;Les limites d\u2019une ordonnance de type Norwich : l\u2019importation parall\u00e8le, le \u00ab march\u00e9 gris \u00bb et les impacts de la s\u00e9rialisation&nbsp;\u00bb [2020] <em>ROBIC, LLP Publications<\/em>, <a href=\"https:\/\/www.robic.ca\/en\/publications\/the-limitations-of-a-norwich-order-parallel-imports-grey-market-goods-and-the-impacts-of-serialization\/\">The Limitations of a Norwich Order: Parallel Imports, \u201cGrey Market\u201d Goods and the Impacts of Serialization<\/a><\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u201cPrevalence and Characterization of Subclinical Coronary Atherosclerotic Plaque with CT among Individuals with HIV: Results from the Canadian HIV and Aging Cohort Study\u201d. <em>Radiology<\/em>, 203297. Advance online publication, 2021, <a href=\"https:\/\/doi.org\/10.1148\/radiol.2021203297\">https:\/\/doi.org\/10.1148\/radiol.2021203297<\/a>.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u201cUpregulated IL-32 Expression and Reduced Gut Short Chain Fatty Acid Caproic Acid in People Living With HIV With Subclinical Atherosclerosis\u201d. <em>Frontiers in Immunology, 12<\/em>(1235), 2021, <a href=\"https:\/\/doi.org\/10.3389\/fimmu.2021.664371\">https:\/\/doi.org\/10.3389\/fimmu.2021.664371<\/a>.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u201cAssociation of Epicardial Fat with Non-Calcified Coronary Plaque Volume and With Low Attenuation Plaque in People Living with HIV\u201d,&nbsp;<em>AIDS (London, England)<\/em>: 1<sup>er<\/sup> ao\u00fbt&nbsp;2021 &#8211; Volume 35 &#8211; \u00c9mission 10 &#8211; p 1575-1584, <a href=\"https:\/\/doi.org\/10.1097\/qad.0000000000002911\">https:\/\/doi.org\/10.1097\/qad.0000000000002911<\/a>.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u201cQuantification of epicardial fat using non-contrast cardiac CT in an HIV population: Reproducibility and association with other body fat indices\u201d, <em>European Journal of Radiology Open, <\/em>8, 100317, 2021, <a href=\"https:\/\/doi.org\/10.1016\/j.ejro.2020.100317\">https:\/\/doi.org\/10.1016\/j.ejro.2020.100317<\/a> &nbsp;<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u00ab&nbsp;Perception, intentions et anxi\u00e9t\u00e9 par rapport \u00e0 la sant\u00e9 cardiovasculaire dans la Cohorte canadienne VIH et vieillissement \u2013 Comparaison avec les facteurs de risque cardiovasculaire et les donn\u00e9es de la tomodensitom\u00e9trie cardiaque&nbsp;\u00bb, Soci\u00e9t\u00e9 de radiologie du Qu\u00e9bec (SRQ), congr\u00e8s annuel, Montr\u00e9al, 2019.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u00ab&nbsp;Quantification par tomodensitom\u00e9trie et mesure de l\u2019association avec l\u2019ath\u00e9roscl\u00e9rose coronarienne subclinique&nbsp;\u00bb, Soci\u00e9t\u00e9 de radiologie du Qu\u00e9bec (SRQ), congr\u00e8s annuel, Montr\u00e9al, 2019.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u201cReproducibility of epicardial fat quantification using non-contrast cardiac CT in an HIV population\u201d (poster), Canadian Association of Radiologists Annual Scientific Meeting, Montr\u00e9al, 12 avril 2019.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u201cIncidental findings in CT imaging of coronary artery bypass grafts: results from a Canadian multicenter prospective cohort\u201d, <em>BMC Res Notes, 11<\/em>(1), 72. <a href=\"https:\/\/doi.org\/10.1186\/s13104-018-3168-1\">https:\/\/doi.org\/10.1186\/s13104-018-3168-1<\/a>.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u201cEpicardial Fat is Increased in the HIV Population and Associated to Coronary Artery Plaque Burden\u201d, Radiological Society of North America 2018 Scientific Assembly and Annual Meeting, 25 novembre &#8211; 30 novembre, 2018, Chicago IL.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u201cEpicardial fat is increased in the HIV population and associated to coronary plaque burden\u201d, 27th Annual Canadian Conference on HIV\/AIDS Research (CAHR 2018).<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u201cUnexpected locations of sentinel lymph nodes in endometrial cancer\u201d, <em>Gynecologic Oncology<\/em>, Juillet 2017, <a href=\"https:\/\/doi.org\/10.1016\/j.ygyno.2017.07.125\">https:\/\/doi.org\/10.1016\/j.ygyno.2017.07.125<\/a>.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u201cOutcomes of patients with preoperative grade I endometrial cancer and sentinel lymph node mapping\u201d, <em>Gynecologic Oncology, 145<\/em>, 196, Juin 2017, <a href=\"https:\/\/doi.org\/10.1016\/j.ygyno.2017.03.449\">https:\/\/doi.org\/10.1016\/j.ygyno.2017.03.449<\/a>.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u201cUnexpected locations of sentinel lymph nodes in endometrial cancer\u201d, <em>Gynecologic Oncology, 145<\/em>, 52-53, Juin 2017, <a href=\"http:\/\/dx.doi.org\/10.1016\/j.ygyno.2017.03.129\">http:\/\/dx.doi.org\/10.1016\/j.ygyno.2017.03.129<\/a>.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u201cIn vivo coronary artery plaque assessment with computed tomography angiography: is there an impact of iterative reconstruction on plaque volume and attenuation metrics?\u201d, <em>Acta Radiol, 58<\/em>(6), 660-669, Juin 2017, <a href=\"https:\/\/doi.org\/10.1177\/0284185116664229\">https:\/\/doi.org\/10.1177\/0284185116664229<\/a>.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u00ab&nbsp;Association de la graisse \u00e9picardique mesur\u00e9e par scanner cardiaque avec la maladie coronarienne chez les patients VIH positifs&nbsp;\u00bb, Journ\u00e9e des \u00e9tudiants SIDA-MI FRQS, 2017, Montr\u00e9al.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u00ab&nbsp;Association de la graisse \u00e9picardique mesur\u00e9e par scanner cardiaque avec la maladie coronarienne chez les patients VIH positifs&nbsp;\u00bb, Soci\u00e9t\u00e9 de Radiologie Qu\u00e9b\u00e9coise, Congr\u00e8s annuel, Novembre 2017, Montr\u00e9al.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u201cEpicardial fat and its association to coronary artery plaque burden in the HIV population\u201d,&nbsp;8e Journ\u00e9e scientifique du CRCHUM, Octobre 2017, Montr\u00e9al.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 <em>\u201c<\/em>Pulmonary computed tomography angiography in the diagnosis of acute pulmonary embolism: an assessment of prevalence and use\u201d, Canadian Association of Radiologists Annual Scientific Meeting, Avril 2017, Montr\u00e9al.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u201cEpicardial fat quantitative assessment and its relationship to computed tomography markers of coronary artery plaque vulnerability in HIV patients\u201d, The 26th Annual Canadian Conference on HIV\/AIDS Research, Avril 2017, Montr\u00e9al.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u00ab&nbsp;Embolie pulmonaire en tomodensitom\u00e9trie : \u00e9tude de pr\u00e9valence et d\u2019utilisation&nbsp;\u00bb, Journ\u00e9e acad\u00e9mique du d\u00e9partement de radiologie, radio-oncologie et m\u00e9decine nucl\u00e9aire de la facult\u00e9 de m\u00e9decine de l\u2019Universit\u00e9 de Montr\u00e9al, F\u00e9vrier 2017, Universit\u00e9 de Montr\u00e9al.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u00ab&nbsp;\u00c9valuation in vivo de la plaque coronarienne en tomodensitom\u00e9trie \u2013 la reconstruction it\u00e9rative influence-t-elle la mesure du volume et de l\u2019att\u00e9nuation de la plaque?&nbsp;\u00bb, RBIQ (R\u00e9seau de bio-imagerie du Qu\u00e9bec), 8<sup>e<\/sup> Journ\u00e9e scientifique, Janvier 2016, Montr\u00e9al.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u201cIn vivo coronary artery plaque assessment with computed tomography angiography \u2013 is there an impact of iterative reconstruction on plaque volume and attenuation metrics?\u201d, RSNA Scientific Assembly and Annual Meeting, McCormick Place, D\u00e9cembre 2015, Chicago, Illinois.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 \u201cIn vivo coronary artery plaque assessment with computed tomography angiography \u2013 is there an impact of iterative reconstruction on plaque volume and attenuation metrics?\u201d, American Roentgen Ray Society scientific meeting, Avril 2015, Toronto.<\/li>\n\n\n\n<li>Co-Auteur d\u2019un article intitul\u00e9 <em>\u00ab&nbsp;L&rsquo;effet de la reconstruction it\u00e9rative compar\u00e9e \u00e0 la r\u00e9troprojection filtr\u00e9e sur l&rsquo;analyse de plaques coronariennes en angiographie coronarienne par tomodensitom\u00e9trie&nbsp;\u00bb,<\/em> Congr\u00e8s des stagiaires du COPSE, Janvier 2015, Universit\u00e9 de Montr\u00e9al.<\/li>\n<\/ul>\n\n\n\n<p><strong>Conf\u00e9rences: <\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Conf\u00e9renci\u00e8re de \u201cSubclinical coronary atherosclerosis among individuals with HIV on antiretroviral therapy \u2013 Baseline results from the Canadian HIV and Aging Cohort Study\u201d, Canadian Cardiovascular Congress Annual Meeting 2019, Montr\u00e9al, 24 octobre &#8211; 27 octobre 2019.<\/li>\n\n\n\n<li>Conf\u00e9renci\u00e8re de \u201cSubclinical coronary atherosclerosis among individuals with HIV on anti retroviral therapy\u201d, Canadian Association of Radiologists Annual Scientific Meeting, Montr\u00e9al, 12 avril 2019.<\/li>\n\n\n\n<li>Conf\u00e9renci\u00e8re de \u201cSubclinical coronary atherosclerosis among individuals with HIV on antiretroviral therapy &#8211; Baseline results from the Canadian HIV and Aging Cohort Study\u201d, Journ\u00e9e universitaire du d\u00e9partement de radiologie, radio-oncologie et m\u00e9decine nucl\u00e9aire de la facult\u00e9 de m\u00e9decine de l\u2019Universit\u00e9 de Montr\u00e9al, Universit\u00e9 de Montr\u00e9al, 21 f\u00e9vrier 2019.<\/li>\n\n\n\n<li>Conf\u00e9renci\u00e8re de \u201cSubclinical Coronary Atherosclerosis among Individuals with HIV on Antiretroviral Therapy\u201d, Radiological Society of North America 2018 Scientific Assembly and Annual Meeting, 25&nbsp;novembre &#8211; 30 novembre 2018, Chicago IL.<\/li>\n\n\n\n<li>Conf\u00e9renci\u00e8re de \u201cIncidental findings in CT imaging of coronary artery bypass grafts &#8211; Results from the Canadian PATENCY-CORONARY trial\u201d, Canadian Association of Radiologists Annual Scientific Meeting, 28 mai &#8211; 30 mai 2015, Montr\u00e9al.<\/li>\n\n\n\n<li>Conf\u00e9renci\u00e8re de \u201cCoronary artery bypass graft imaging with 256-slice MDCT angiography and iterative reconstruction method: quantitive evaluation of image quality and radiation dose reduction\u201d, Canadian Association of Radiologists Annual Scientific Meeting, 28 mai &#8211; 30 mai 2015, Montr\u00e9al.<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image size-large is-resized\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"345\" src=\"https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/Irina_Boldeanu-1024x345.png\" alt=\"\" class=\"wp-image-6313\" style=\"width:226px;height:auto\" srcset=\"https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/Irina_Boldeanu-1024x345.png 1024w, https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/Irina_Boldeanu-300x101.png 300w, https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/Irina_Boldeanu-768x258.png 768w, https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/Irina_Boldeanu-1536x517.png 1536w, https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/Irina_Boldeanu-2048x689.png 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n","protected":false},"author":4,"featured_media":5303,"menu_order":0,"template":"","meta":{"_acf_changed":true},"equipe_cat":[20],"class_list":["post-5307","equipe","type-equipe","status-publish","has-post-thumbnail","hentry","equipe_cat-avocats"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Boldeanu Irina - Lapointe Rosenstein Marchand Melan\u00e7on<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lrmm.com\/fr\/e-quipe\/avocats\/boldeanu-irina\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Boldeanu Irina - Lapointe Rosenstein Marchand Melan\u00e7on\" \/>\n<meta property=\"og:description\" content=\"Irina Boldeanu s\u2019est jointe \u00e0 notre \u00e9quipe de litige en 2023. Reconnue dans les \u00e9ditions de Best Lawyers: Ones to Watch in Canada\u00ae depuis 2024, Irina est une avocate en litige d\u00e9vou\u00e9e et ax\u00e9e sur les r\u00e9sultats, passionn\u00e9e par les litiges civils et commerciaux complexes, notamment la d\u00e9fense d\u2019actions collectives et les litiges commerciaux. Elle [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lrmm.com\/fr\/e-quipe\/avocats\/boldeanu-irina\" \/>\n<meta property=\"og:site_name\" content=\"Lapointe Rosenstein Marchand Melan\u00e7on\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-04T15:36:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/YKP_6109rc-157x157-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"157\" \/>\n\t<meta property=\"og:image:height\" content=\"157\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.lrmm.com\/fr\/e-quipe\/avocats\/boldeanu-irina\",\"url\":\"https:\/\/www.lrmm.com\/fr\/e-quipe\/avocats\/boldeanu-irina\",\"name\":\"Boldeanu Irina - Lapointe Rosenstein Marchand Melan\u00e7on\",\"isPartOf\":{\"@id\":\"https:\/\/www.lrmm.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.lrmm.com\/fr\/e-quipe\/avocats\/boldeanu-irina#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.lrmm.com\/fr\/e-quipe\/avocats\/boldeanu-irina#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/YKP_6109rc-157x157-1.jpg\",\"datePublished\":\"2024-01-05T22:46:10+00:00\",\"dateModified\":\"2025-09-04T15:36:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.lrmm.com\/fr\/e-quipe\/avocats\/boldeanu-irina#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.lrmm.com\/fr\/e-quipe\/avocats\/boldeanu-irina\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.lrmm.com\/fr\/e-quipe\/avocats\/boldeanu-irina#primaryimage\",\"url\":\"https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/YKP_6109rc-157x157-1.jpg\",\"contentUrl\":\"https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/YKP_6109rc-157x157-1.jpg\",\"width\":157,\"height\":157},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.lrmm.com\/fr\/e-quipe\/avocats\/boldeanu-irina#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.lrmm.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u00c9quipe\",\"item\":\"https:\/\/www.lrmm.com\/fr\/e-quipe\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Boldeanu Irina\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.lrmm.com\/fr\/#website\",\"url\":\"https:\/\/www.lrmm.com\/fr\/\",\"name\":\"Lapointe Rosenstein Marchand Melan\u00e7on\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.lrmm.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Boldeanu Irina - Lapointe Rosenstein Marchand Melan\u00e7on","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lrmm.com\/fr\/e-quipe\/avocats\/boldeanu-irina\/","og_locale":"fr_CA","og_type":"article","og_title":"Boldeanu Irina - Lapointe Rosenstein Marchand Melan\u00e7on","og_description":"Irina Boldeanu s\u2019est jointe \u00e0 notre \u00e9quipe de litige en 2023. Reconnue dans les \u00e9ditions de Best Lawyers: Ones to Watch in Canada\u00ae depuis 2024, Irina est une avocate en litige d\u00e9vou\u00e9e et ax\u00e9e sur les r\u00e9sultats, passionn\u00e9e par les litiges civils et commerciaux complexes, notamment la d\u00e9fense d\u2019actions collectives et les litiges commerciaux. Elle [&hellip;]","og_url":"https:\/\/www.lrmm.com\/fr\/e-quipe\/avocats\/boldeanu-irina","og_site_name":"Lapointe Rosenstein Marchand Melan\u00e7on","article_modified_time":"2025-09-04T15:36:26+00:00","og_image":[{"width":157,"height":157,"url":"https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/YKP_6109rc-157x157-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.lrmm.com\/fr\/e-quipe\/avocats\/boldeanu-irina","url":"https:\/\/www.lrmm.com\/fr\/e-quipe\/avocats\/boldeanu-irina","name":"Boldeanu Irina - Lapointe Rosenstein Marchand Melan\u00e7on","isPartOf":{"@id":"https:\/\/www.lrmm.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.lrmm.com\/fr\/e-quipe\/avocats\/boldeanu-irina#primaryimage"},"image":{"@id":"https:\/\/www.lrmm.com\/fr\/e-quipe\/avocats\/boldeanu-irina#primaryimage"},"thumbnailUrl":"https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/YKP_6109rc-157x157-1.jpg","datePublished":"2024-01-05T22:46:10+00:00","dateModified":"2025-09-04T15:36:26+00:00","breadcrumb":{"@id":"https:\/\/www.lrmm.com\/fr\/e-quipe\/avocats\/boldeanu-irina#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lrmm.com\/fr\/e-quipe\/avocats\/boldeanu-irina"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.lrmm.com\/fr\/e-quipe\/avocats\/boldeanu-irina#primaryimage","url":"https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/YKP_6109rc-157x157-1.jpg","contentUrl":"https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/YKP_6109rc-157x157-1.jpg","width":157,"height":157},{"@type":"BreadcrumbList","@id":"https:\/\/www.lrmm.com\/fr\/e-quipe\/avocats\/boldeanu-irina#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.lrmm.com\/fr\/"},{"@type":"ListItem","position":2,"name":"\u00c9quipe","item":"https:\/\/www.lrmm.com\/fr\/e-quipe\/"},{"@type":"ListItem","position":3,"name":"Boldeanu Irina"}]},{"@type":"WebSite","@id":"https:\/\/www.lrmm.com\/fr\/#website","url":"https:\/\/www.lrmm.com\/fr\/","name":"Lapointe Rosenstein Marchand Melan\u00e7on","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lrmm.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"}]}},"_links":{"self":[{"href":"https:\/\/www.lrmm.com\/fr\/wp-json\/wp\/v2\/equipe\/5307","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lrmm.com\/fr\/wp-json\/wp\/v2\/equipe"}],"about":[{"href":"https:\/\/www.lrmm.com\/fr\/wp-json\/wp\/v2\/types\/equipe"}],"author":[{"embeddable":true,"href":"https:\/\/www.lrmm.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.lrmm.com\/fr\/wp-json\/wp\/v2\/media\/5303"}],"wp:attachment":[{"href":"https:\/\/www.lrmm.com\/fr\/wp-json\/wp\/v2\/media?parent=5307"}],"wp:term":[{"taxonomy":"equipe_cat","embeddable":true,"href":"https:\/\/www.lrmm.com\/fr\/wp-json\/wp\/v2\/equipe_cat?post=5307"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}